FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011032401> ?p ?o ?g. }

• W2011032401 endingPage "41" @default.
• W2011032401 startingPage "31" @default.
• W2011032401 abstract "Background Diabetes and hypertension are potent risk factors for end-stage renal disease (ESRD). Previous studies suggest that other cardiovascular risk factors also may increase the risk of ESRD; however, risk associated with a comprehensive cardiovascular risk-factor assessment has not been quantified in a population-based sample. Study Design The Atherosclerosis Risk in Communities (ARIC) Study, a prospective observational cohort. Setting & Participants 15,324 white and African American participants aged 45-64 years from 4 US communities were followed up after a baseline visit that occurred in 1987-1989. Predictor A comprehensive collection of cardiovascular risk factors were examined. Outcomes & Measurements Incidence of ESRD (transplant, dialysis, catheter placement or kidney failure, and death) exclusive of acute kidney failure was ascertained through active surveillance of hospitalizations through 2004. Results During a median 16-year follow-up, 241 cases of ESRD developed (incidence rate, 1.04 cases/1,000 person-years). Male sex, African American race, diabetes, hypertension, history of coronary heart disease, smoking, older age, body mass index, and triglyceride concentration were associated with increased risk of ESRD after adjustment for baseline estimated glomerular filtration rate (eGFR) and each other. There was a graded curvilinear association between risk of ESRD and lower baseline eGFR at levels < 90 mL/min/1.73 m2 and moderately increased levels > 120 mL/min/1.73 m2. The relative risk of eGFR on ESRD risk generally was greater in women and individuals with diabetes than in their counterparts. Limitations Only events occurring in acute-care hospitals were investigated (but there was long-term continuous active surveillance of events). Conclusions We quantify the relative risk of ESRD in a community-based African American and white population associated with established cardiovascular risk factors (diabetes, hypertension, male sex, and African American race) and report prospective data identifying greater risk of ESRD associated with other cardiovascular risk factors: moderately decreased eGFR, increased eGFR, higher body mass index, smoking, and increased triglyceride level. Diabetes and hypertension are potent risk factors for end-stage renal disease (ESRD). Previous studies suggest that other cardiovascular risk factors also may increase the risk of ESRD; however, risk associated with a comprehensive cardiovascular risk-factor assessment has not been quantified in a population-based sample. The Atherosclerosis Risk in Communities (ARIC) Study, a prospective observational cohort. 15,324 white and African American participants aged 45-64 years from 4 US communities were followed up after a baseline visit that occurred in 1987-1989. A comprehensive collection of cardiovascular risk factors were examined. Incidence of ESRD (transplant, dialysis, catheter placement or kidney failure, and death) exclusive of acute kidney failure was ascertained through active surveillance of hospitalizations through 2004. During a median 16-year follow-up, 241 cases of ESRD developed (incidence rate, 1.04 cases/1,000 person-years). Male sex, African American race, diabetes, hypertension, history of coronary heart disease, smoking, older age, body mass index, and triglyceride concentration were associated with increased risk of ESRD after adjustment for baseline estimated glomerular filtration rate (eGFR) and each other. There was a graded curvilinear association between risk of ESRD and lower baseline eGFR at levels < 90 mL/min/1.73 m2 and moderately increased levels > 120 mL/min/1.73 m2. The relative risk of eGFR on ESRD risk generally was greater in women and individuals with diabetes than in their counterparts. Only events occurring in acute-care hospitals were investigated (but there was long-term continuous active surveillance of events). We quantify the relative risk of ESRD in a community-based African American and white population associated with established cardiovascular risk factors (diabetes, hypertension, male sex, and African American race) and report prospective data identifying greater risk of ESRD associated with other cardiovascular risk factors: moderately decreased eGFR, increased eGFR, higher body mass index, smoking, and increased triglyceride level." @default.
• W2011032401 created "2016-06-24" @default.
• W2011032401 creator A5002731748 @default.
• W2011032401 creator A5047227825 @default.
• W2011032401 creator A5062912167 @default.
• W2011032401 date "2010-01-01" @default.
• W2011032401 modified "2023-10-15" @default.
• W2011032401 title "Risk of Incident ESRD: A Comprehensive Look at Cardiovascular Risk Factors and 17 Years of Follow-up in the Atherosclerosis Risk in Communities (ARIC) Study" @default.
• W2011032401 cites W1979562724 @default.
• W2011032401 cites W1981364767 @default.
• W2011032401 cites W1994560902 @default.
• W2011032401 cites W2015573357 @default.
• W2011032401 cites W2018901137 @default.
• W2011032401 cites W2028599784 @default.
• W2011032401 cites W2039063847 @default.
• W2011032401 cites W2046550573 @default.
• W2011032401 cites W2062032763 @default.
• W2011032401 cites W2068126254 @default.
• W2011032401 cites W2076749936 @default.
• W2011032401 cites W2080760372 @default.
• W2011032401 cites W2091142003 @default.
• W2011032401 cites W2096796626 @default.
• W2011032401 cites W2099422638 @default.
• W2011032401 cites W2104202991 @default.
• W2011032401 cites W2107412805 @default.
• W2011032401 cites W2108807575 @default.
• W2011032401 cites W2114019720 @default.
• W2011032401 cites W2116404316 @default.
• W2011032401 cites W2122730408 @default.
• W2011032401 cites W2126202552 @default.
• W2011032401 cites W2128572614 @default.
• W2011032401 cites W2132647859 @default.
• W2011032401 cites W2141365440 @default.
• W2011032401 cites W2144352130 @default.
• W2011032401 cites W2146353453 @default.
• W2011032401 cites W2159843374 @default.
• W2011032401 cites W2169437554 @default.
• W2011032401 cites W4242416368 @default.
• W2011032401 cites W4300044462 @default.
• W2011032401 doi "https://doi.org/10.1053/j.ajkd.2009.09.006" @default.
• W2011032401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19932544" @default.
• W2011032401 hasPublicationYear "2010" @default.
• W2011032401 type Work @default.
• W2011032401 sameAs 2011032401 @default.
• W2011032401 citedByCount "91" @default.
• W2011032401 countsByYear W20110324012012 @default.
• W2011032401 countsByYear W20110324012013 @default.
• W2011032401 countsByYear W20110324012014 @default.
• W2011032401 countsByYear W20110324012015 @default.
• W2011032401 countsByYear W20110324012016 @default.
• W2011032401 countsByYear W20110324012017 @default.
• W2011032401 countsByYear W20110324012018 @default.
• W2011032401 countsByYear W20110324012019 @default.
• W2011032401 countsByYear W20110324012020 @default.
• W2011032401 countsByYear W20110324012021 @default.
• W2011032401 countsByYear W20110324012022 @default.
• W2011032401 countsByYear W20110324012023 @default.
• W2011032401 crossrefType "journal-article" @default.
• W2011032401 hasAuthorship W2011032401A5002731748 @default.
• W2011032401 hasAuthorship W2011032401A5047227825 @default.
• W2011032401 hasAuthorship W2011032401A5062912167 @default.
• W2011032401 hasConcept C120665830 @default.
• W2011032401 hasConcept C121332964 @default.
• W2011032401 hasConcept C126322002 @default.
• W2011032401 hasConcept C134018914 @default.
• W2011032401 hasConcept C159641895 @default.
• W2011032401 hasConcept C188816634 @default.
• W2011032401 hasConcept C2778063415 @default.
• W2011032401 hasConcept C2778653478 @default.
• W2011032401 hasConcept C2779978075 @default.
• W2011032401 hasConcept C2780221984 @default.
• W2011032401 hasConcept C2908647359 @default.
• W2011032401 hasConcept C3019040382 @default.
• W2011032401 hasConcept C50440223 @default.
• W2011032401 hasConcept C555293320 @default.
• W2011032401 hasConcept C61511704 @default.
• W2011032401 hasConcept C71924100 @default.
• W2011032401 hasConcept C99454951 @default.
• W2011032401 hasConceptScore W2011032401C120665830 @default.
• W2011032401 hasConceptScore W2011032401C121332964 @default.
• W2011032401 hasConceptScore W2011032401C126322002 @default.
• W2011032401 hasConceptScore W2011032401C134018914 @default.
• W2011032401 hasConceptScore W2011032401C159641895 @default.
• W2011032401 hasConceptScore W2011032401C188816634 @default.
• W2011032401 hasConceptScore W2011032401C2778063415 @default.
• W2011032401 hasConceptScore W2011032401C2778653478 @default.
• W2011032401 hasConceptScore W2011032401C2779978075 @default.
• W2011032401 hasConceptScore W2011032401C2780221984 @default.
• W2011032401 hasConceptScore W2011032401C2908647359 @default.
• W2011032401 hasConceptScore W2011032401C3019040382 @default.
• W2011032401 hasConceptScore W2011032401C50440223 @default.
• W2011032401 hasConceptScore W2011032401C555293320 @default.
• W2011032401 hasConceptScore W2011032401C61511704 @default.
• W2011032401 hasConceptScore W2011032401C71924100 @default.
• W2011032401 hasConceptScore W2011032401C99454951 @default.
• W2011032401 hasFunder F4320332161 @default.
• W2011032401 hasFunder F4320337338 @default.
• W2011032401 hasIssue "1" @default.

• next